EFG Performance — iShares MSCI EAFE Growth ETF
Data updated: 2026-10-13
EFG returned +7.42% year to date and +15.92% over one year to Jul 2026. Annualised returns are +9.94% over 3 years and +3.94% over 5 years. The fund beat its International Large Growth category average: $100 invested three years ago grew to $133, against $132 for the category, and to $116 over one year, against $113. Volatility over the past three years was 14.93% a year. In the 12 months to Jul 2026 the fund took in a net $2.2B, and assets reached $16.60B.
EFG Growth of $100
What $100 invested in iShares MSCI EAFE Growth ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the International Large Growth category average over the same months.
| Period | EFG | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $116 | $113 |
| 3 years (Aug 2023 – Jul 2026) | $133 | $132 |
| 5 years (Aug 2021 – Jul 2026) | $121 | $114 |
| Since data start (Aug 2019 – Jul 2026) | $168 | $174 |
EFG Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +7.42% |
| 1 year | +15.92% |
| 3 years (annualised) | +9.94% |
| 5 years (annualised) | +3.94% |
EFG Annual Returns
Calendar-year total returns of iShares MSCI EAFE Growth ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +7.42% |
| 2025 | +20.68% |
| 2024 | +1.45% |
| 2023 | +17.25% |
| 2022 | −22.92% |
| 2021 | +10.95% |
| 2020 | +17.97% |
| 2019 (Aug–Dec) | +8.21% |
EFG Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +4.6% | +3.4% | −9.5% | +7.1% | +3.4% | +1.5% | −2.3% | — | — | — | — | — |
| 2025 | +5.1% | +1.4% | −3.1% | +4.6% | +5.1% | +3.0% | −4.3% | +3.4% | +3.1% | +1.3% | −1.4% | +1.3% |
| 2024 | +0.2% | +4.5% | +2.3% | −4.7% | +5.2% | −1.1% | +1.4% | +4.0% | +0.3% | −6.4% | +0.1% | −3.5% |
| 2023 | +9.0% | −3.8% | +6.0% | +2.3% | −2.8% | +3.4% | +1.4% | −4.8% | −6.2% | −2.7% | +9.9% | +5.8% |
| 2022 | −9.4% | −3.6% | −0.3% | −8.0% | +0.1% | −8.3% | +8.0% | −7.2% | −9.8% | +4.9% | +14.4% | −3.4% |
| 2021 | −1.4% | −0.4% | +1.2% | +4.2% | +3.2% | −0.1% | +1.8% | +2.1% | −4.3% | +3.9% | −3.3% | +4.0% |
| 2020 | −0.6% | −8.6% | −9.2% | +7.3% | +5.5% | +3.2% | +4.4% | +4.4% | −0.7% | −4.0% | +12.3% | +4.8% |
| 2019 | — | — | — | — | — | — | — | −1.2% | +1.1% | +3.5% | +1.7% | +2.8% |
EFG Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 14.93%
- 3-year Sharpe ratio: 0.36 (vs 4.5% risk-free rate)
- Best month: +9.91% (Nov 2023)
- Worst month: −9.51% (Mar 2026)
EFG Fund Flows
Monthly money in and out of iShares MSCI EAFE Growth ETF, from SEC Form N-PORT.
- 12-month net flow: $2.2B
- 12-month gross sales (incl. reinvestments): $6.4B
- Sales ÷ redemptions: 1.54×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $97.9M | $0 | $97.9M |
| Jun 2026 | $838.8M | $0 | $838.8M |
| May 2026 | $243.5M | $0 | $243.5M |
| Apr 2026 | $283.4M | $0 | $283.4M |
| Mar 2026 | $4.8B | $0 | $4.8B |
| Feb 2026 | $0 | $0 | $0 |
| Jan 2026 | $0 | $0 | $0 |
| Dec 2025 | $45.2M | $90.7M | −$45.5M |
| Nov 2025 | $4 | $89.2M | −$89.2M |
| Oct 2025 | $0 | $137.9M | −$137.9M |
| Sep 2025 | $44.0M | $3.9B | −$3.8B |
| Aug 2025 | $88.7M | $0 | $88.7M |
EFG Assets Under Management
Net assets of iShares MSCI EAFE Growth ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $16.60B |
| 2026-04-30 | $15.18B |
| 2026-01-31 | $9.81B |
| 2025-10-31 | $9.68B |
| 2025-07-31 | $12.61B |
| 2025-04-30 | $12.55B |
| 2025-01-31 | $16.12B |
| 2024-10-31 | $14.36B |
| 2024-07-31 | $15.20B |
| 2024-04-30 | $11.62B |
| 2024-01-31 | $11.22B |
| 2023-10-31 | $9.46B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.